Table 2.
Study | Total Number of Hip Fracture Patients | COVID-19 Test Status |
Number of Nonoperative COVID + Patients | Overall Postoperative Mortality | COVID + Postoperative Mortality | ||
---|---|---|---|---|---|---|---|
COVID+ | COVID- | Untested/Undefined COVID-19 Status | |||||
LeBrun et al. | 59 | 9 | 40 | 10 | 2 | 4 | 3/7 (42.9%) |
Munoz Vives et al. | 136 | 23 | 39 | 74 | 8 | 5 | 2/15 (13.3%) |
Cheung & Forsh | 10 | 10 | 0 | 0 | 0 | 1 | 1/10 (10.0%) |
Maniscalco et al. | 121 | 32 | 32 | 57 | 0 | 17 | 14/32 (43.8) |
Egol et al. | 138 | 17 | 107 | 14 | 4 | 15 | 7/13 (53.8%) |
Catellani et al. | 16 | 16 | 0 | 0 | 3 | 4 | 4/13 (30.8%) |
Mi et al. | 6 | 6 | 0 | 0 | 3 | 1 | 1/3 (33.3%) |
Hall et al. | 317 | 27 | 290 | 0 | 2 | 17 | 7/25 (28%) |
Kayani et al. | 422 | 82 | 340 | 0 | 0 | 60 | 25/82 (30.5%) |
Thakrar et al.a | 43 | 12 | 6 | 25 | 0 | 7 | 4/12 (33.3%) |
Segarra et al. | 68 | 2 | 59 | 7 | 0 | 8 | 1/2 (50.0%) |
Sobti et al. | 94 | 6 | 47 | 41 | 0 | 9 | 3/6 (50.0%) |
Malik-Tabassum et al. | 68 | 1 | 51 | 16 | 1 | 6 | 0/0 |
Rabie et al. | 4 | 4 | 0 | 0 | 3 | 0 | 0/1 |
Narang et al. | 682 | 86 | 0 | 596 | 0 | 66 | 30/86 (34.9%) |
Dupley et al. | 64 | 64 | 0 | 0 | 6 | 17 | 17/58 (29.3%) |
2248 | 397 | 1011 | 840 | 32 | 237 | 119/365 (32.6%) |
Data obtained from authors.